Product Information

TETRABENAZINE 12.5 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.7604 per EA under NDC 69452011721. Its NADAC has been published 183 times since Feb 22, 2023.

FDA first approved this application on Dec 18, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TETRABENAZINE 12.5 MG TABLET

TETRABENAZINE
$0.7604per EA

Strength

12.5 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452011721

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TETRABENAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA208826

FDA Approved

12/18/2017

TE Code

AB

On Market Since

1/15/2018

Pharmacological Classes

Vesicular Monoamine Transporter 2 Inhibitor
Vesicular Monoamine Transporter 2 Inhibitors

Price Statistics

The NADAC for TETRABENAZINE 12.5 MG TABLET has been published 183 times since Feb 22, 2023, and over the history we have for it it has declined 70.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7604 per EA
All-time high$3.2465 (Dec 13, 2023)
All-time low$0.7604 (Aug 19, 2026)
52-week high$0.8066
52-week low$0.7604
Median price$1.4241
Average price$1.6800
Largest weekly change-63.3% (Dec 20, 2023)
Weeks tracked183
Tracking sinceFeb 22, 2023

Price History

1W

-4.7%

1M

-4.7%

3M

-5.5%

6M

-1.0%

1Y

-3.7%

3Y

-76.6%

5Y

N/A

All

-70.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of TETRABENAZINE 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 12.5 MG TABLET, manufactured by Bionpharma Inc., is $0.7604 per EA (NDC 69452011721), effective Aug 19, 2026.

How has the price of TETRABENAZINE 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TETRABENAZINE 12.5 MG TABLET has declined 70.7%. It has been tracked across 183 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for TETRABENAZINE 12.5 MG TABLET?

Since Feb 22, 2023, the NADAC for TETRABENAZINE 12.5 MG TABLET has ranged from a low of $0.7604 (Aug 19, 2026) to a high of $3.2465 (Dec 13, 2023), with a median of $1.4241 per EA.

Are there cheaper alternatives to TETRABENAZINE 12.5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TETRABENAZINE 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TETRABENAZINE 12.5 MG TABLET?

TETRABENAZINE 12.5 MG TABLET (NDC 69452011721) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.